Last reviewed · How we verify

Propofol+ Rocuronium+ Fentanyl + Inhalational

Memorial Sloan Kettering Cancer Center · Phase 3 active Small molecule

This is a combination anesthetic regimen that induces unconsciousness, provides muscle paralysis, and delivers pain relief for surgical procedures.

This is a combination anesthetic regimen that induces unconsciousness, provides muscle paralysis, and delivers pain relief for surgical procedures. Used for Induction and maintenance of general anesthesia for surgical procedures.

At a glance

Generic namePropofol+ Rocuronium+ Fentanyl + Inhalational
SponsorMemorial Sloan Kettering Cancer Center
Drug classGeneral anesthetic combination
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhasePhase 3

Mechanism of action

Propofol is an intravenous hypnotic agent that depresses the central nervous system to induce and maintain anesthesia. Rocuronium is a neuromuscular blocking agent that paralyzes skeletal muscles by blocking acetylcholine receptors at the neuromuscular junction. Fentanyl is an opioid analgesic that provides intraoperative analgesia, while inhalational agents (likely sevoflurane or isoflurane) maintain anesthetic depth throughout the procedure.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: